|
Corporate Information
For information about the company or general inquiries, please
contact us at:
Advanced Proteome Therapeutics Inc.
Suite 113
650 Albany Street
Boston, Massachusetts
02118 USA
T 617-638-0340
F 617-638-0341
www.advancedproteome.com
info@advancedproteome.com
TSX-V Listed: APC
CUSIP: 007628
Year End: July 31
Shares Issued and Outstanding:
71,004,461
Transfer Agent:
Computershare Investor Services Inc.
Officers and Directors:
Dr. Allen (Alexander) Krantz, President, CEO and Director
Jean Bellin, Director
Dr. Gary Hayes, MD, Director
Kenneth C. Phillippe, CFO
Scientific Advisory Board
Professor Paul A. Wender
Professor Stephen Hanessian, F.R.S.C., O.C.
Professor Stephen G. Withers
Auditor:
BDO Dunwoody LLP
Investor Contact:
Phone: 1-800-APT-1169
Fax: 617-638-0341
admin@advancedproteome.com
|
